Clinical Research Directory
Browse clinical research sites, groups, and studies.
Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
Sponsor: Brigham and Women's Hospital
Summary
This study will test a remote approach to help people who may be at higher risk for pancreatic cancer learn about and decide whether to get genetic testing and a blood test that looks for signs of several cancers (MCED testing). The study is focused on Black, Latino/a, and Medicaid-enrolled individuals who may have had less access to cancer genetics and early detection services. About 80 participants, who reside in Massachusetts, will be assigned by chance to receive either online education alone or online education plus a phone call with a trained educator from the Pancreatic Cancer Action Network (PanCAN). After the education, participants can choose whether or not to have genetic testing and/or MCED testing. The main goal is to learn whether this approach is practical to carry out, acceptable to participants, and delivered as planned. Participants will complete 3 surveys during study participation.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-09
Completion Date
2029-03
Last Updated
2026-08-26
Healthy Volunteers
No
Conditions
Interventions
Telephone education session
Participants will receive a telephone call from a trained navigator at PanCAN to provide \~20mins of information about genetic testing and MCED testing.
Online educational materials
Participants will receive links to test information provided by the testing company.
Locations (1)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States